Drug Type CAR-T |
Synonyms anti-HER2 CAR T-cell therapy (Prescient Therapeutics Ltd) |
Target |
Action- |
Mechanism HER2 modulators(Receptor protein-tyrosine kinase erbB-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | Australia | - | |
Ovarian Cancer | Preclinical | Australia | - | |
Stomach Cancer | Preclinical | Australia | - |